Biodesix, Inc. (BDSX)
BDSX Stock Price Chart
Explore Biodesix, Inc. interactive price chart. Choose custom timeframes to analyze BDSX price movements and trends.
BDSX Company Profile
Discover essential business fundamentals and corporate details for Biodesix, Inc. (BDSX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
28 Oct 2020
Employees
273.00
Website
https://www.biodesix.comCEO
Scott Hutton
Description
Biodesix, Inc. is a data-driven diagnostic solutions provider operating across the United States. Its primary focus includes a comprehensive suite of blood-based lung tests, marketed as the Nodify Lung Nodule Risk Assessment (which includes Nodify XL2 and Nodify CDT). These assessments enable clinicians to evaluate the risk of lung cancer in patients with suspicious nodules, aiding in the reclassification of malignancy risk and guiding appropriate treatment pathways. Beyond risk assessment, Biodesix offers additional lung cancer diagnostics such as GeneStrat ddPCR, which detects specific tumor mutations, and VeriStrat, which gauges the patient's immune system status. Both are crucial for establishing prognosis and informing treatment plans. Another offering is the GeneStrat NGS (Next-Generation Sequencing) test, a rapid, blood-based sequencing solution providing results within 72 hours. Through a partnership with Bio-Rad Laboratories, Inc., Biodesix also provides COVID-19 testing services under its Biodesix WorkSafe program, featuring the Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 Total Ab test, an antibody assay for detecting a B-cell immune response indicating recent or prior infection. Furthermore, the company extends its expertise to biopharmaceutical companies, offering diagnostic and clinical research services, alongside clinical trial testing. It also actively discovers, develops, and commercializes companion diagnostics. Originally incorporated as Elston Technologies, Inc. in 2005, Biodesix, Inc. maintains its headquarters in Boulder, Colorado.
BDSX Financial Timeline
Browse a chronological timeline of Biodesix, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$0.86, while revenue estimate is $26.03m.
Earnings released on 4 May 2026
EPS came in at -$0.81 surpassing the estimated -$1.26 by +35.71%, while revenue for the quarter reached $25.56m , beating expectations by +10.52%.
Earnings released on 26 Feb 2026
EPS came in at -$0.49 surpassing the estimated -$1.05 by +53.33%, while revenue for the quarter reached $28.76m , beating expectations by +11.77%.
Earnings released on 3 Nov 2025
EPS came in at -$1.16 surpassing the estimated -$1.60 by +27.50%, while revenue for the quarter reached $21.77m , missing expectations by -17.07%.
Stock split effective on 15 Sept 2025
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 7 Aug 2025
EPS came in at -$1.60 falling short of the estimated -$1.40 by -14.29%, while revenue for the quarter reached $20.02m , beating expectations by +8.40%.
Earnings released on 13 May 2025
EPS came in at -$0.08 matching the estimated -$0.08, while revenue for the quarter reached $17.96m , missing expectations by -20.42%.
Earnings released on 3 Mar 2025
EPS came in at -$0.06 surpassing the estimated -$0.07 by +14.29%, while revenue for the quarter reached $20.43m , beating expectations by +0.54%.
Earnings released on 1 Nov 2024
EPS came in at -$0.07 surpassing the estimated -$0.08 by +12.50%, while revenue for the quarter reached $18.15m , missing expectations by -8.48%.
Earnings released on 7 Aug 2024
EPS came in at -$0.08 surpassing the estimated -$0.09 by +11.11%, while revenue for the quarter reached $17.93m , beating expectations by +10.58%.
Earnings released on 8 May 2024
EPS came in at -$0.14 surpassing the estimated -$0.15 by +6.67%, while revenue for the quarter reached $14.82m , beating expectations by +4.50%.
Earnings released on 1 Mar 2024
EPS came in at -$0.10 surpassing the estimated -$0.11 by +9.09%, while revenue for the quarter reached $14.67m , missing expectations by -6.03%.
Earnings released on 7 Nov 2023
EPS came in at -$0.12 surpassing the estimated -$0.15 by +20.00%, while revenue for the quarter reached $13.49m , missing expectations by -13.52%.
Earnings released on 7 Aug 2023
EPS came in at -$0.17 surpassing the estimated -$0.21 by +19.05%, while revenue for the quarter reached $11.87m , beating expectations by +1.73%.
Earnings released on 11 May 2023
EPS came in at -$0.24 surpassing the estimated -$0.26 by +7.69%, while revenue for the quarter reached $9.06m , beating expectations by +4.09%.
Earnings released on 6 Mar 2023
EPS came in at -$0.28 falling short of the estimated -$0.26 by -7.69%, while revenue for the quarter reached $9.61m , missing expectations by -10.80%.
Earnings released on 3 Nov 2022
EPS came in at -$0.34 falling short of the estimated -$0.32 by -6.25%, while revenue for the quarter reached $11.11m , beating expectations by +9.38%.
Earnings released on 4 Aug 2022
EPS came in at -$0.40 surpassing the estimated -$0.47 by +14.89%, while revenue for the quarter reached $10.95m , beating expectations by +24.08%.
Earnings released on 11 May 2022
EPS came in at -$0.50 falling short of the estimated -$0.38 by -31.58%, while revenue for the quarter reached $6.55m , beating expectations by +1.26%.
Earnings released on 14 Mar 2022
EPS came in at -$0.49 surpassing the estimated -$0.50 by +2.00%, while revenue for the quarter reached $7.22m , missing expectations by -0.88%.
Earnings released on 15 Nov 2021
EPS came in at -$0.50 matching the estimated -$0.50, while revenue for the quarter reached $6.53m , missing expectations by -13.27%.
Earnings released on 10 Aug 2021
EPS came in at -$0.41 falling short of the estimated -$0.31 by -32.26%, while revenue for the quarter reached $11.89m , missing expectations by -43.78%.
BDSX Stock Performance
Access detailed BDSX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
